Target, Home Depot,...
Services: Diversified Services
Genetic Technologies Limited (GENE: NASDAQ)
$2.85 0.17 | 6.34%
05/17/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| GENE | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 3.47 | 5.56 | 135.09 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | -40.60 | 0.26 | 0.08 |
| Net Income | 0.00 | 0.00 | |
| EPS | -100.00 | -0.31 | 0.00 |
Earnings for GENE:
| EBITDA | -5.00 |
| REVENUE | 11.60M |
Average Earnings Estimates
| Qtr (03/13) | Qtr (06/13) | FY (06/13) | FY (06/14) | |
|---|---|---|---|---|
| Average Estimate | $n.a. | $n.a. | $-0.47 | $-0.26 |
| Number of Analysts | 0 | 0 | 1 | 1 |
| High Estimate | $n.a. | $n.a. | $-0.47 | $-0.26 |
| Low Estimate | $n.a. | $n.a. | $-0.47 | $-0.26 |
| Prior Year | $n.a. | $n.a. | $-0.36 | $-0.47 |
| Growth Rate (Year over Year) | n.a.% | n.a.% | -30.56% | 44.68% |
Portfolios with GENE
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor14 Penny Stocks Get Delisti...
- UserExperimental Equities
- UserMBW
- Userann's prorfolio
Latest GENE Headlines from TheStreet
- STUDY VALIDATES BREVAGen MORE ACCURATELY IDENTIFIES BREAST CANCER RISK LEADING TO INCREASED BREAST HEALTH COMPLIANCE 04.15.13 | 12:04 pm
- The Centers For Women's Health In Stamford CT Pioneers Breast Cancer Risk Assessment 03.18.13 | 12:03 pm
- 5 Stocks Ready to Break Out 02.22.13 | 12:02 pm
- 4 Stocks Under $10 Making Big Moves 10.19.12 | 02:10 pm
- 4 Biotech Stocks Under $10 Soaring Higher 09.25.12 | 02:09 pm
- 8 Stocks Under $10 Ripping Higher 01.26.12 | 02:01 pm
- Optimer Soars on Antibiotic Data 11.11.08 | 12:11 pm
- Biotech Buzz: Big Strides in Alzheimer's Drugs
01.10.08 | 05:01 pm - Funny Money 12.10.07 | 01:12 pm
- Ties May Bind Apple's CEO to Board 09.06.06 | 04:09 pm
Press Releases for GENE
- BREVAGen Reclassified 64% Of Intermediate Gail Risk Subjects(1) (Graphic: Business Wire) - Business Wire 04.10.12 | 09:04 am
- Break-Through Invention For Treating Cancer - Business Wire 11.07.11 | 10:11 am
- Genetic Technologies Limited Announces Quarterly Activities Report For The Quarter Ended 30 September 2011 - Business Wire 10.26.11 | 11:10 am
- Genetic Technologies’ BREVAGen™ Changing The Way US Physicians Assess Breast Cancer Risk - Business Wire 10.18.11 | 09:10 am
- Genetic Technologies Limited Appoints Dr. Mervyn Cass As Company Director - Business Wire 10.03.11 | 10:10 am
Partner Headlines for GENE
- Morning Market Losers - Benzinga 11.28.12 | 09:11 am
- Genetic Technologies Executes Covenant Not to Sue And Release Agreement with One Lambda - Benzinga 10.18.12 | 01:10 pm
- 3 Best Biotech Stocks For This Week (Part VI) - Seeking Alpha 10.16.12 | 08:10 am
- Morning Market Movers - Benzinga 09.25.12 | 09:09 am
- Genetic Technologies Moving On News This Morning - Seeking Alpha 08.08.12 | 09:08 am
- Healthcare Business Recap: Merck's Potential AIDS CURE, Genetic Tech SPIKES - Wall St. Cheat Sheet 07.27.12 | 08:07 am
- Genetic Technologies Executes Exclusive Distribution Agreement with Rosetta Genomics - Benzinga 06.01.12 | 01:06 pm
- Netflix, Take-Two Among Stocks Attracting Investors and Traders Now - Wall St. Cheat Sheet 05.23.12 | 02:05 am
- Afternoon Market Top Percentage Gainers and Losers (CAAS, GENE, HNSN, SYMX, TPX, SCOK, QXM, IDIX, AIB, HERO) - Benzinga 04.08.11 | 01:04 pm
